Synchron Stock

synchron.comHealthcareFounded: 2016

Synchron is a developer an endovascular brain computer interface or Neurointerventional Electrophysiology technology to help map, restore and treat individuals with neurological disabilities.

Register for Details

For more details on financing and valuation for Synchron, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Synchron.

Register Today

Team

Management Team

Thomas Oxley Ph.D
Co-Founder, Chief Executive Officer & Board Member
Nicholas Opie Ph.D
Co-Founder, Chief Technology Officer & Board Member
Amos Meltzer
Chief Legal Officer
Rahul Sharma
Co-Founder & Board Member
J Mocco
Chief Medical Officer

Board Members

Alexander Morgan Ph.D
Khosla Ventures
Ari Nowacek Ph.D
ARCH Venture Partners
Martin Dieck
NeuroTechnology Investors
Robert Nelsen
ARCH Venture Partners

Other companies like Synchron in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$303.94MM
Sector
Last Round Est. Valuation
$298.33MM
Sector
Last Round Est. Valuation
$1.08B
Sector
 
 
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$4.26B